The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.13706
Abstract: Essentials Reversal of anticoagulant effects of dabigatran may occur despite application of idarucizumab. Monitoring of dabigatran level after antidote application is crucial to detect rebound. Repeated doses of idarucizumab may be necessary in cases of… read more here.
Keywords: idarucizumab may; dose idarucizumab; dabigatran; recommended dose ... See more keywords